treatment of the product of cyclization with Meerwein’s
DMF-dimethylacetal.11,12
Scheme 2. Preparation of Guanine Analogue 2
The trichloromethyl group of 6 can also be converted to
an amino group of 9 by treatment with methanolic NH3; this
provides a convenient alternative to the previously reported2
synthesis of purinoid 1.
The preparations of 3 (the isoguanine analogue) and 4 (the
xanthine analogue) start from the preformed imidazole moi-
ety of the bicyclic heterocycles.13,2 Treatment of 5-amino-
imidazole in dioxane (prepared in situ by catalytic hydro-
genation of 5-nitro-imidazole13,14) with N-cyano-isocyanate-
dimethylacetal15,16 gives the bicyclic 2-methoxy-6-amino
derivative 10, the methoxy group of which is cleaved, pre-
sumably via N-protonation(s) followed by SN2 substitution
at the methyl carbon, to the carbonyl group of 3 by HBr in
acetic acid. Alternatively, reaction of 5-amino-imidazole in
dioxane with phenyloxycarbonyl-isocyanate17 affords the
intermediate 11, which smoothly cyclizes to 4 by heating in
ethanolic solution.
The methods used for preparing purinoids 2 (Scheme 2),
3 (Scheme 3), and 4 (Scheme 3) were chosen without re-
The isoguanine analogue 3 was obtained as a white solid
which, in contrast to 2, is only sparingly soluble in DMSO
and insoluble in H2O or CH3OH. The compound is thermally
stable to heating (in a closed tube) to 190 °C for 10 h. The
xanthine analogue 4 crystallized in colorless cubes from eth-
anol; it is soluble in DMSO, H2O, and CH3OH, and its con-
stitution was confirmed by X-ray analysis.10 The UV spectra
of 1-4, in which all absorption maxima are hypsochromic
relative to those of the corresponding purines, are reproduced
in Figure 1.9
Scheme 3. Preparation of 3 and 4
Scheme 4 summarizes our experiments on the C-nucleo-
sidation of the guanine analogue 2 with the previously
described pyrroline derivative 12.3 Treatment of 1.0 mol
equiv of 2 in DMF (c ) 0.2 M) with 1.1 mol equiv of 12 in
the presence of 1.1 proton equivalents (p-TsOH‚H2O) at
room temperature for 2 h afforded the corresponding
C-nucleosides essentially quantitatively, as revealed by direct
(NH)-protection of the reaction product in the reaction
mixture with (BOC)2O/Et3N followed by chromatography
course to the potentially etiological aspects that we associate
with these nucleobase analogues. N-Formyl-glycyl-guanidine
5, easily obtained from N-formyl-glycine ethylester4 and
guanidine,5 reacts with trichloroacetonitrile to give the
trichloromethyl-triazine derivative 6, which, following the
methodology described by Kelarev et al.,6 is hydrolytically
converted to 7. Remarkably, as well as satisfyingly, when
this N-formyl-aminomethyl-triazine is treated with concen-
trated H2SO4 at 100 °C, a procedure reported in the literature
for the cyclization of other keto-amino-triazine derivatives,7
dehydrative cyclization proceeds regioselectively and gives
the guanine analogue 2 in high yield; the isomeric cyclization
product is not observed.8 1H and 13C NMR spectra of 2 are
compatible with the assigned constitution;9 the proof, hard
to come by spectroscopically, is based on X-ray structure
analysis10 of the derivative 8, formed in high yield by mild
(8) Considering the harsh reaction conditions (concentrated H2SO4, 100°
C) and the multitude of protonation sites in the substrate, we refrain from
attempting to rationalize the observed regioselectivity of the cyclization.
(9) NMR and mass spectral properties, see Supporting Information.
(10) X-ray structure analysis of 4 and 8 was carried out by Dr. Bernd
Schweizer, ETH-Z. Crystallographic data for the structure has been deposited
with the Cambridge Crystallographic Data Center as deposition no. CCDC
242452 for 8 and no. CCDC 242453 for 4. Copies of the data can be
obtained, free of charge, on application to the CCDC, 12 Union Rd.,
Cambridge CB12 1EZ, UK (fax: +44 (1233) 336 0333; e-mail: deposit@
ccdc.cam.ac.uk). Data of 4 and 8 can be found in Supporting Information.
(11) Reaction of 2 with DMF-dimethylacetal in methanol at room
temperature produces, besides 8, small amounts of a side product containing
an additional dimethylamino-methylidene group at carbon C-9.
(12) Koch, G. (Novartis AG, Basel) Private communication: Underiva-
tized 2 could be obtained in crystalline form and as such subjected to X-ray
structure analysis (work by G. Koch and B. Wagner (Novartis)).
(13) Al-Shaar, A. H. M.; Chambers, R. K.; Gilmour, D. W.; Lythgoe,
D. J.; McClenaghan, I.; Ramsden, C. A. J. Chem. Soc., Perkin Trans. 1
1992, 2789.
(4) Martin, P. K.; Matthews, H. R.; Rapoport, H.; Thyagarajan, G. J.
Org. Chem. 1968, 33, 3758.
(5) Procedure for the preparation of N-formyl-L-valyl-guanidine by:
Hoffmann, E.; Diller, D. Can. J. Chem. 1965, 43, 3103.
(6) Kelarev, V. I.; Ammar Dibi; Lunin, A. F. Chem. Heterocycl. Compd.
(NY) 1985, 21, 1284; English translation from Khim. Geterotsikl. Soedin.
1985, 21, 1557.
(14) Rabinowitz, J. C. J. Biol. Chem. 1956, 218, 175.
(15) Prepared by heating cyanamide in tetramethyl orthocarbonate at 95
°C in 76% yield (mp 56-58° C) according to Kantlehner et al.16 but using
tetramethyl- instead of tetraethyl-orthocarbonate in order to avoid the for-
mation of a mixture of O- and N-ethylated isomers (see procedure in Sup-
porting Information).
(16) Kantlehner, W.; Maier, T.; Lo¨ffler, W.; Kapassakalidis, J. J. Liebigs
Ann. Chem. 1982, 507.
(7) Kim, S.-H.; Bartholomew, D. G.; Allen, L. B.; Robins, R. K.;
Revankar, G. R.; Dea, P. J. Med. Chem. 1978, 21, 883.
(17) Rao, P.; Benner, S. A. J. Org. Chem. 2001, 66, 5012.
3692
Org. Lett., Vol. 6, No. 21, 2004